CannaPharmaRX, Inc. (CPMD)

Market Cap	1.28M -39.2%
Revenue (ttm)	1.65M +46.4%
Net Income	-10.82M
EPS	-0.02
Shares Out	672.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,000
Open	0.0019
Previous Close	0.0019
Day's Range	0.0019 - 0.0019
52-Week Range	0.0003 - 0.0100
Beta	-1,518.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About CannaPharmaRX

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Constantine Nkafu
• Employees: 26
• Stock Exchange: OTCMKTS
• Ticker Symbol: CPMD

Financial Performance

In 2025, CannaPharmaRX's revenue was $1.36 million, an increase of 66.09% compared to the previous year's $820,137. Losses were -$11.13 million, 12.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 17, 2026

Data Sources Report a data error